Ms Dudek was promoted to chief technical officer in November 2023; she joined Arcutis as vice president of quality in August 2020. Prior to joining Arcutis, Ms Dudek was at Kite Pharma, where she held roles of increasing responsibility, culminating in the role of executive director of quality Europe, where she was responsible for all aspects of quality to support supply and distribution of cell therapy products in EU and non-EU countries and was responsible for quality assurance and quality control for new clinical and commercial manufacturing sites for cell therapy products. Prior to Kite, Ms Dudek was senior director of quality assurance at Kythera Biopharmaceuticals, where she was responsible for oversight of the quality assurance organization as it transitioned from development to commercial operations for Kybella®. Earlier in her career she was technical operations head, pediatrics and specialty franchise at Novartis Vaccines and Diagnostics. Previously, Ms Dudek held various roles of increasing responsibility at Amgen, Inc., culminating in the role of director, global operations leader. Ms Dudek received her BA in biology from Ithaca College.